(Q35750598)

10 August 2017

1 reference

title

Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials (English)

1 reference

10 August 2017

1 reference

1 reference

2

1 reference

10 August 2017

4

1 reference

10 August 2017

3

Diane Heels-Ansdell

1 reference

10 August 2017

7

Pablo Alonso-Coello

1 reference

10 August 2017

5

Elie A Akl

1 reference

10 August 2017

18

Gordon H Guyatt

1 reference

10 August 2017

Dianne M Bryant

6

0 references

Jordi Alonso

8

Jordi Alonso

1 reference

10 August 2017

12

Holger J Schünemann

1 reference

10 August 2017

17

Edward J Mills

1 reference

10 August 2017

11

Roman Jaeschke

1 reference

Ignacio Ferreira-González

10 August 2017

1

Ignacio Ferreira-González

1 reference

10 August 2017

Gaietà Permanyer-Miralda

13

Gaietà Permanyer-Miralda

1 reference

10 August 2017

Valeria Pacheco-Huergo

14

Valeria Pacheco-Huergo

1 reference

10 August 2017

Antonia Domingo-Salvany

15

Antònia Domingo-Salvany

1 reference

10 August 2017

Andrew Worster

9

1 reference

10 August 2017

Suneel Upadhye

10

1 reference

10 August 2017

Ping Wu

16

1 reference

10 August 2017

language of work or name

English

0 references

publication date

2 April 2007

1 reference

10 August 2017

1 reference

10 August 2017

334

1 reference

10 August 2017

7597

1 reference

10 August 2017

786

1 reference

Validity of composite end points in clinical trials

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852019

Measuring inconsistency in meta-analyses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852019

Lessons learned from recent cardiovascular clinical trials: Part I.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852019

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852019

A method of assigning scores to the components of a composite outcome: An example from the MITI trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852019

Composite outcomes in randomized trials: greater precision but with greater uncertainty?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852019

Combined endpoints: can we use them?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852019

One thousand health-related quality-of-life estimates

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852019

Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts

25 September 2018

1 reference

12 December 2020

Patients at the center: in our practice, and in our use of language

1 reference

12 December 2020

An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point

1 reference

12 December 2020

Key issues in end point selection for heart failure trials: composite end points

1 reference

12 December 2020

10.1136/BMJ.39136.682083.AE

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference